$PCVX Cashflow Statement | Understand Stock

$PCVX

$59.97 -$0.46 (0.76%) Close

$PCVX Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities:
Net loss
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization
Stock-based compensation expense
Non-cash payments for acquired manufacturing rights
Change in fair value of redeemable convertible preferred stock warrant
Loss on disposal of assets
Asset impairment charges
Amortization of operating lease right-of-use assets
Net accretion of discounts on investments
Unrealized foreign exchange loss (gain)
Changes in operating assets and liabilities:
Prepaid expenses and other current assets
Operating lease right-of-use assets
Other assets
Operating lease liabilities
Accounts payable
Accrued compensation
Accrued contract manufacturing expenses
Accrued expenses
Deferred rent and other long-term liabilities

Net cash used in operating activities

Cash flows from investing activities:
Purchases of property and equipment
Purchases of manufacturing facility build-out and equipment construction-in-progress
Purchases of investments
Maturities of investments
Sales of investments
Proceeds from sales of property and equipment
Net cash provided by (used in) investing activities
Cash flows from financing activities:
Payments of capital lease obligations
Proceeds from initial public offering, net of issuance costs
Proceeds from issuance of common stock and pre-funded warrants from follow-on offerings, net of issuance costs
Proceeds from issuance of redeemable convertible preferred stock, net of issuance costs
Proceeds from exercise of common stock options
Proceeds from issuance of common stock related to early exercised stock options
Proceeds from issuance of common stock under at-the-market offering, net of issuance costs
Proceeds from issuance of shares through employee equity incentive plans
Taxes paid related to the net share settlement of equity awards
Net cash provided by financing activities

Effect of exchange rate changes on cash and cash equivalents
Net decrease in cash, cash equivalents and restricted cash
Cash, cash equivalents and restricted cash, beginning of period
Cash, cash equivalents and restricted cash, end of period
Cash paid for interest
Supplemental disclosures of non-cash investing and financing activities:
Purchases of property and equipment recorded in accounts payable and accrued expenses
Issuance of common stock for acquired manufacturing rights
Conversion of convertible preferred stock into common stock
Stock issued for payment of accounts payable
Deferred offering costs included in accounts payable and accrued expenses

Cash and cash equivalents
Restricted cash

Comments